| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microfilament motor activity | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B MYO19 MYH15 | 7.17e-24 | 38 | 93 | 14 | GO:0000146 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B MYO19 MYH15 | 2.88e-16 | 118 | 93 | 14 | GO:0003774 |
| GeneOntologyMolecularFunction | actin filament binding | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B MYO19 MYH15 | 2.70e-12 | 227 | 93 | 14 | GO:0051015 |
| GeneOntologyMolecularFunction | calmodulin binding | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 OBSCN MYH15 | 5.15e-11 | 230 | 93 | 13 | GO:0005516 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 SETX MYH13 MYH14 MYH7B MYO19 MYH15 CHD6 AQR | 3.10e-09 | 614 | 93 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | actin binding | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B MYO19 MYH15 MEFV | 5.67e-09 | 479 | 93 | 15 | GO:0003779 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B MYO19 TUBGCP3 MYLIP OBSCN MYH15 MEFV CAPN10 | 5.98e-07 | 1099 | 93 | 19 | GO:0008092 |
| GeneOntologyMolecularFunction | poly(A) RNA polymerase activity | 2.09e-05 | 12 | 93 | 3 | GO:1990817 | |
| GeneOntologyMolecularFunction | N-acetyllactosaminide alpha-2,3-sialyltransferase activity | 2.15e-05 | 2 | 93 | 2 | GO:0008118 | |
| GeneOntologyMolecularFunction | adenylyltransferase activity | 4.00e-04 | 31 | 93 | 3 | GO:0070566 | |
| GeneOntologyMolecularFunction | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity | 4.44e-04 | 7 | 93 | 2 | GO:0003836 | |
| GeneOntologyMolecularFunction | myosin light chain binding | 5.90e-04 | 8 | 93 | 2 | GO:0032027 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 1.05e-03 | 43 | 93 | 3 | GO:0008307 | |
| GeneOntologyMolecularFunction | phosphatidyl phospholipase B activity | 1.15e-03 | 11 | 93 | 2 | GO:0102545 | |
| GeneOntologyMolecularFunction | integrin binding | 1.36e-03 | 175 | 93 | 5 | GO:0005178 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 1.29e-09 | 153 | 90 | 10 | GO:0030048 | |
| GeneOntologyBiologicalProcess | muscle filament sliding | 4.10e-09 | 15 | 90 | 5 | GO:0030049 | |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 1.16e-08 | 18 | 90 | 5 | GO:0033275 | |
| GeneOntologyBiologicalProcess | muscle contraction | 9.67e-06 | 400 | 90 | 10 | GO:0006936 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 1.97e-05 | 127 | 90 | 6 | GO:0070252 | |
| GeneOntologyBiologicalProcess | myofibril assembly | 3.73e-05 | 86 | 90 | 5 | GO:0030239 | |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH14 MYH7B MYO19 OBSCN LRP1 CAPN10 | 3.90e-05 | 912 | 90 | 14 | GO:0030029 |
| GeneOntologyBiologicalProcess | striated muscle cell development | 4.40e-05 | 89 | 90 | 5 | GO:0055002 | |
| GeneOntologyBiologicalProcess | actin filament bundle distribution | 5.63e-05 | 3 | 90 | 2 | GO:0070650 | |
| GeneOntologyBiologicalProcess | actomyosin structure organization | 8.48e-05 | 239 | 90 | 7 | GO:0031032 | |
| GeneOntologyBiologicalProcess | muscle system process | 1.35e-04 | 547 | 90 | 10 | GO:0003012 | |
| GeneOntologyCellularComponent | myosin filament | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B OBSCN MYH15 | 1.56e-27 | 25 | 92 | 14 | GO:0032982 |
| GeneOntologyCellularComponent | myosin II complex | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B MYH15 | 3.41e-24 | 28 | 92 | 13 | GO:0016460 |
| GeneOntologyCellularComponent | myosin complex | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B MYO19 MYH15 | 4.12e-21 | 59 | 92 | 14 | GO:0016459 |
| GeneOntologyCellularComponent | muscle myosin complex | 1.29e-15 | 16 | 92 | 8 | GO:0005859 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 KALRN MYH14 MYH7B MYO19 MYH15 | 3.10e-08 | 576 | 92 | 15 | GO:0015629 |
| GeneOntologyCellularComponent | contractile muscle fiber | 6.02e-08 | 290 | 92 | 11 | GO:0043292 | |
| GeneOntologyCellularComponent | myosin II filament | 8.25e-08 | 3 | 92 | 3 | GO:0097513 | |
| GeneOntologyCellularComponent | myofibril | 3.44e-07 | 273 | 92 | 10 | GO:0030016 | |
| GeneOntologyCellularComponent | supramolecular fiber | CYLD RASSF5 MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B KRT74 TUBGCP3 OBSCN MYH15 MEFV | 7.29e-07 | 1179 | 92 | 19 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | CYLD RASSF5 MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B KRT74 TUBGCP3 OBSCN MYH15 MEFV | 8.07e-07 | 1187 | 92 | 19 | GO:0099081 |
| GeneOntologyCellularComponent | contractile actin filament bundle | 1.10e-04 | 107 | 92 | 5 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 1.10e-04 | 107 | 92 | 5 | GO:0001725 | |
| GeneOntologyCellularComponent | sarcomere | 1.16e-04 | 249 | 92 | 7 | GO:0030017 | |
| GeneOntologyCellularComponent | actomyosin | 1.68e-04 | 117 | 92 | 5 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 1.75e-04 | 118 | 92 | 5 | GO:0032432 | |
| GeneOntologyCellularComponent | actomyosin contractile ring | 3.97e-04 | 7 | 92 | 2 | GO:0005826 | |
| GeneOntologyCellularComponent | cell division site | 4.30e-04 | 80 | 92 | 4 | GO:0032153 | |
| GeneOntologyCellularComponent | semaphorin receptor complex | 1.45e-03 | 13 | 92 | 2 | GO:0002116 | |
| GeneOntologyCellularComponent | A band | 1.56e-03 | 52 | 92 | 3 | GO:0031672 | |
| GeneOntologyCellularComponent | contractile ring | 1.68e-03 | 14 | 92 | 2 | GO:0070938 | |
| Domain | Myosin_N | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B MYH15 | 5.02e-29 | 15 | 93 | 13 | PF02736 |
| Domain | Myosin_N | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B MYH15 | 5.02e-29 | 15 | 93 | 13 | IPR004009 |
| Domain | Myosin_tail_1 | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B MYH15 | 4.05e-27 | 18 | 93 | 13 | PF01576 |
| Domain | Myosin_tail | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B MYH15 | 4.05e-27 | 18 | 93 | 13 | IPR002928 |
| Domain | Myosin-like_IQ_dom | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B MYH15 | 1.28e-26 | 19 | 93 | 13 | IPR027401 |
| Domain | - | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B MYH15 | 1.28e-26 | 19 | 93 | 13 | 4.10.270.10 |
| Domain | Myosin_head_motor_dom | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B MYO19 MYH15 | 1.82e-23 | 38 | 93 | 14 | IPR001609 |
| Domain | MYOSIN_MOTOR | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B MYO19 MYH15 | 1.82e-23 | 38 | 93 | 14 | PS51456 |
| Domain | Myosin_head | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B MYO19 MYH15 | 1.82e-23 | 38 | 93 | 14 | PF00063 |
| Domain | MYSc | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B MYO19 MYH15 | 1.82e-23 | 38 | 93 | 14 | SM00242 |
| Domain | IQ | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B MYO19 OBSCN MYH15 | 5.03e-19 | 93 | 93 | 15 | PS50096 |
| Domain | IQ | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B MYO19 OBSCN | 2.89e-18 | 81 | 93 | 14 | SM00015 |
| Domain | IQ_motif_EF-hand-BS | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B MYO19 OBSCN | 1.38e-17 | 90 | 93 | 14 | IPR000048 |
| Domain | IQ | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 OBSCN | 1.12e-15 | 71 | 93 | 12 | PF00612 |
| Domain | - | 1.20e-07 | 3 | 93 | 3 | 3.30.70.590 | |
| Domain | PAP_central | 1.20e-07 | 3 | 93 | 3 | PF04928 | |
| Domain | PAP_RNA-bind | 1.20e-07 | 3 | 93 | 3 | PF04926 | |
| Domain | PolA_pol_cen_dom | 1.20e-07 | 3 | 93 | 3 | IPR007012 | |
| Domain | PolA_pol_RNA-bd_dom | 1.20e-07 | 3 | 93 | 3 | IPR007010 | |
| Domain | PolyA_polymerase | 1.20e-07 | 3 | 93 | 3 | IPR014492 | |
| Domain | NuclTrfase_I_C | 1.20e-07 | 3 | 93 | 3 | IPR011068 | |
| Domain | P-loop_NTPase | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 SETX MYH13 MYH14 MYH7B MYO19 MYH15 GIMAP1 CHD6 AQR | 1.65e-07 | 848 | 93 | 18 | IPR027417 |
| Domain | NTP_transf_2 | 1.92e-05 | 11 | 93 | 3 | PF01909 | |
| Domain | Polymerase_NTP_transf_dom | 1.92e-05 | 11 | 93 | 3 | IPR002934 | |
| Domain | UPF0028 | 2.45e-05 | 2 | 93 | 2 | PS01237 | |
| Domain | Myosin_S1_N | 2.43e-04 | 5 | 93 | 2 | IPR008989 | |
| Domain | ConA-like_dom | 7.92e-04 | 219 | 93 | 6 | IPR013320 | |
| Domain | Patatin/PLipase_A2-rel | 8.63e-04 | 9 | 93 | 2 | IPR002641 | |
| Domain | Patatin | 8.63e-04 | 9 | 93 | 2 | PF01734 | |
| Domain | PNPLA | 8.63e-04 | 9 | 93 | 2 | PS51635 | |
| Domain | LAM_G_DOMAIN | 8.89e-04 | 38 | 93 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 1.03e-03 | 40 | 93 | 3 | PF02210 | |
| Domain | LamG | 1.37e-03 | 44 | 93 | 3 | SM00282 | |
| Domain | Sialyl_trans | 2.47e-03 | 15 | 93 | 2 | IPR012163 | |
| Domain | Laminin_G | 3.03e-03 | 58 | 93 | 3 | IPR001791 | |
| Domain | Acyl_Trfase/lysoPLipase | 3.18e-03 | 17 | 93 | 2 | IPR016035 | |
| Domain | Integrin_alpha-2 | 3.56e-03 | 18 | 93 | 2 | IPR013649 | |
| Domain | Integrin_alpha2 | 3.56e-03 | 18 | 93 | 2 | PF08441 | |
| Domain | Integrin_alpha | 3.56e-03 | 18 | 93 | 2 | IPR000413 | |
| Domain | INTEGRIN_ALPHA | 3.56e-03 | 18 | 93 | 2 | PS00242 | |
| Domain | DH_1 | 3.82e-03 | 63 | 93 | 3 | PS00741 | |
| Domain | Int_alpha_beta-p | 3.97e-03 | 19 | 93 | 2 | IPR013519 | |
| Domain | Int_alpha | 3.97e-03 | 19 | 93 | 2 | SM00191 | |
| Domain | Glyco_trans_29 | 4.40e-03 | 20 | 93 | 2 | IPR001675 | |
| Domain | Glyco_transf_29 | 4.40e-03 | 20 | 93 | 2 | PF00777 | |
| Domain | FA58C | 4.84e-03 | 21 | 93 | 2 | SM00231 | |
| Domain | FA58C_3 | 4.84e-03 | 21 | 93 | 2 | PS50022 | |
| Domain | FA58C_1 | 4.84e-03 | 21 | 93 | 2 | PS01285 | |
| Domain | FA58C_2 | 4.84e-03 | 21 | 93 | 2 | PS01286 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B MYH15 | 8.38e-17 | 70 | 80 | 13 | M12294 |
| Pathway | KEGG_TIGHT_JUNCTION | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B MYH15 | 4.32e-13 | 132 | 80 | 13 | M11355 |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 7.52e-08 | 20 | 80 | 5 | M18415 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 2.03e-07 | 24 | 80 | 5 | M2243 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 1.59e-06 | 64 | 80 | 6 | M7923 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 3.49e-06 | 19 | 80 | 4 | M27493 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_CIT | 3.49e-06 | 19 | 80 | 4 | M27489 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 5.35e-06 | 21 | 80 | 4 | M27494 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 7.84e-06 | 23 | 80 | 4 | MM15222 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 2.05e-05 | 29 | 80 | 4 | M27309 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 1.73e-04 | 92 | 80 | 5 | M27201 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.17e-04 | 21 | 80 | 3 | MM15706 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.87e-04 | 23 | 80 | 3 | M556 | |
| Pathway | REACTOME_GLYCEROPHOSPHOLIPID_CATABOLISM | 6.56e-04 | 7 | 80 | 2 | M27657 | |
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 3.31e-16 | 6 | 94 | 6 | 10077619 | |
| Pubmed | 2.31e-15 | 7 | 94 | 6 | 35210422 | ||
| Pubmed | 2.31e-15 | 7 | 94 | 6 | 16819597 | ||
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 1.29e-13 | 5 | 94 | 5 | 3829126 | |
| Pubmed | 1.29e-13 | 5 | 94 | 5 | 6196357 | ||
| Pubmed | 3.02e-13 | 12 | 94 | 6 | 8424456 | ||
| Pubmed | 7.75e-13 | 6 | 94 | 5 | 1728586 | ||
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 7.75e-13 | 6 | 94 | 5 | 10588881 | |
| Pubmed | 7.20e-12 | 8 | 94 | 5 | 3864153 | ||
| Pubmed | 2.39e-11 | 22 | 94 | 6 | 24301466 | ||
| Pubmed | 5.00e-11 | 4 | 94 | 4 | 20357587 | ||
| Pubmed | 5.00e-11 | 4 | 94 | 4 | 1985022 | ||
| Pubmed | 5.00e-11 | 4 | 94 | 4 | 10388558 | ||
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 1.64e-10 | 13 | 94 | 5 | 8404542 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 2.50e-10 | 5 | 94 | 4 | 12919077 | |
| Pubmed | 2.54e-10 | 14 | 94 | 5 | 27184118 | ||
| Pubmed | A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. | 5.52e-10 | 16 | 94 | 5 | 19922871 | |
| Pubmed | 7.47e-10 | 6 | 94 | 4 | 30044719 | ||
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 1.74e-09 | 7 | 94 | 4 | 29758057 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B CTBP2 IPO4 | 2.30e-09 | 647 | 94 | 14 | 26618866 |
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 3.47e-09 | 8 | 94 | 4 | 14667415 | |
| Pubmed | Acceleration of somitic myogenesis in embryos of myogenin promoter-MRF4 transgenic mice. | 1.04e-08 | 10 | 94 | 4 | 8950513 | |
| Pubmed | 1.20e-08 | 58 | 94 | 6 | 21884692 | ||
| Pubmed | 1.63e-08 | 11 | 94 | 4 | 8136524 | ||
| Pubmed | Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. | 1.63e-08 | 11 | 94 | 4 | 16024798 | |
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 1.91e-08 | 3 | 94 | 3 | 26059207 | |
| Pubmed | 1.91e-08 | 3 | 94 | 3 | 36515178 | ||
| Pubmed | 1.91e-08 | 3 | 94 | 3 | 20685736 | ||
| Pubmed | 1.91e-08 | 3 | 94 | 3 | 25567808 | ||
| Pubmed | 1.91e-08 | 3 | 94 | 3 | 15177565 | ||
| Pubmed | 1.91e-08 | 3 | 94 | 3 | 15774463 | ||
| Pubmed | Identification and characterization of nonmuscle myosin II-C, a new member of the myosin II family. | 1.91e-08 | 3 | 94 | 3 | 14594953 | |
| Pubmed | Characterization of three full-length human nonmuscle myosin II paralogs. | 1.91e-08 | 3 | 94 | 3 | 24072716 | |
| Pubmed | 1.91e-08 | 3 | 94 | 3 | 15845534 | ||
| Pubmed | 2.08e-08 | 31 | 94 | 5 | 21985497 | ||
| Pubmed | Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development. | 2.89e-08 | 33 | 94 | 5 | 32094117 | |
| Pubmed | 3.51e-08 | 13 | 94 | 4 | 8948582 | ||
| Pubmed | 4.91e-08 | 14 | 94 | 4 | 24938781 | ||
| Pubmed | Six homeoproteins and a Iinc-RNA at the fast MYH locus lock fast myofiber terminal phenotype. | 6.68e-08 | 15 | 94 | 4 | 24852826 | |
| Pubmed | 6.93e-08 | 39 | 94 | 5 | 38690566 | ||
| Pubmed | 7.63e-08 | 4 | 94 | 3 | 11919279 | ||
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 7.63e-08 | 4 | 94 | 3 | 11029314 | |
| Pubmed | 7.63e-08 | 4 | 94 | 3 | 19948655 | ||
| Pubmed | Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. | 7.63e-08 | 4 | 94 | 3 | 18417546 | |
| Pubmed | Cellular nonmuscle myosins NMHC-IIA and NMHC-IIB and vertebrate heart looping. | 7.63e-08 | 4 | 94 | 3 | 18697221 | |
| Pubmed | Nonmuscle myosins IIA and IIB are present in adult motor nerve terminals. | 7.63e-08 | 4 | 94 | 3 | 16012337 | |
| Pubmed | 7.63e-08 | 4 | 94 | 3 | 11023856 | ||
| Pubmed | 7.63e-08 | 4 | 94 | 3 | 8482409 | ||
| Pubmed | Effect of Mts1 on the structure and activity of nonmuscle myosin II. | 7.63e-08 | 4 | 94 | 3 | 9405067 | |
| Pubmed | 7.63e-08 | 4 | 94 | 3 | 16895968 | ||
| Pubmed | 7.63e-08 | 4 | 94 | 3 | 8491200 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYH1 MYH3 MYH4 MYH9 SETX ADAMTS9 KCNG1 MYO19 OBSCN ST3GAL4 CHD6 ITGAE PLXNB3 | 9.60e-08 | 736 | 94 | 13 | 29676528 |
| Pubmed | 1.16e-07 | 17 | 94 | 4 | 16124007 | ||
| Pubmed | HOXA5 plays tissue-specific roles in the developing respiratory system. | 1.63e-07 | 46 | 94 | 5 | 28827394 | |
| Pubmed | Myosin II regulates extension, growth and patterning in the mammalian cochlear duct. | 1.90e-07 | 5 | 94 | 3 | 19439495 | |
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 33871354 | ||
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 6879174 | ||
| Pubmed | Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections. | 1.90e-07 | 5 | 94 | 3 | 30737693 | |
| Pubmed | Cell-cell adhesions and cell contractility are upregulated upon desmosome disruption. | 1.90e-07 | 5 | 94 | 3 | 25006807 | |
| Pubmed | Telokin expression is restricted to smooth muscle tissues during mouse development. | 1.90e-07 | 5 | 94 | 3 | 11121372 | |
| Pubmed | 3.69e-07 | 54 | 94 | 5 | 22266860 | ||
| Pubmed | Nonmuscle myosin II regulation of lung epithelial morphology. | 3.80e-07 | 6 | 94 | 3 | 22972683 | |
| Pubmed | 3.80e-07 | 6 | 94 | 3 | 15034141 | ||
| Pubmed | 3.80e-07 | 6 | 94 | 3 | 20417199 | ||
| Pubmed | 3.80e-07 | 6 | 94 | 3 | 15292239 | ||
| Pubmed | A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre. | 3.80e-07 | 6 | 94 | 3 | 17559643 | |
| Pubmed | 6.64e-07 | 7 | 94 | 3 | 21126233 | ||
| Pubmed | Nonmuscle myosin II isoform and domain specificity during early mouse development. | 6.64e-07 | 7 | 94 | 3 | 20679233 | |
| Pubmed | Convergence and extrusion are required for normal fusion of the mammalian secondary palate. | 1.06e-06 | 8 | 94 | 3 | 25848986 | |
| Pubmed | 1.06e-06 | 8 | 94 | 3 | 33667029 | ||
| Pubmed | Loss of cell adhesion causes hydrocephalus in nonmuscle myosin II-B-ablated and mutated mice. | 1.06e-06 | 8 | 94 | 3 | 17429076 | |
| Pubmed | 1.06e-06 | 8 | 94 | 3 | 26993635 | ||
| Pubmed | 1.06e-06 | 8 | 94 | 3 | 36200826 | ||
| Pubmed | 1.06e-06 | 8 | 94 | 3 | 33424621 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.34e-06 | 202 | 94 | 7 | 33005030 | |
| Pubmed | 1.59e-06 | 9 | 94 | 3 | 31960486 | ||
| Pubmed | 1.70e-06 | 32 | 94 | 4 | 33732701 | ||
| Pubmed | The expression of myosin genes in developing skeletal muscle in the mouse embryo. | 2.26e-06 | 10 | 94 | 3 | 2211821 | |
| Pubmed | 2.26e-06 | 10 | 94 | 3 | 19506036 | ||
| Pubmed | A point mutation in Myh10 causes major defects in heart development and body wall closure. | 2.26e-06 | 10 | 94 | 3 | 24825879 | |
| Pubmed | 3.11e-06 | 11 | 94 | 3 | 18310078 | ||
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 3.11e-06 | 11 | 94 | 3 | 38303699 | |
| Pubmed | The histone code reader Spin1 controls skeletal muscle development. | 3.11e-06 | 11 | 94 | 3 | 29168801 | |
| Pubmed | Dysregulation of nuclear receptor COUP-TFII impairs skeletal muscle development. | 4.13e-06 | 12 | 94 | 3 | 28600496 | |
| Pubmed | Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4. | 5.36e-06 | 13 | 94 | 3 | 10694423 | |
| Pubmed | Inactivation of the myogenic bHLH gene MRF4 results in up-regulation of myogenin and rib anomalies. | 5.36e-06 | 13 | 94 | 3 | 7797078 | |
| Pubmed | 5.36e-06 | 13 | 94 | 3 | 24876128 | ||
| Pubmed | 5.36e-06 | 13 | 94 | 3 | 26430214 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | RASSF5 MYH1 MYH2 MYH3 MYH6 MYH8 ARHGEF40 MYH13 ARHGAP23 MYH15 CTBP2 CUL7 | 6.40e-06 | 910 | 94 | 12 | 36736316 |
| Pubmed | PTK7 regulates myosin II activity to orient planar polarity in the mammalian auditory epithelium. | 6.81e-06 | 14 | 94 | 3 | 22560610 | |
| Pubmed | 6.81e-06 | 14 | 94 | 3 | 33742095 | ||
| Pubmed | 6.85e-06 | 45 | 94 | 4 | 22114352 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 21792479 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 15013951 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 22328520 | ||
| Pubmed | Regulation of spermatogenesis by testis-specific, cytoplasmic poly(A) polymerase TPAP. | 7.23e-06 | 2 | 94 | 2 | 12471261 | |
| Pubmed | Nonmuscle myosin II-B is required for normal development of the mouse heart. | 7.23e-06 | 2 | 94 | 2 | 9356462 | |
| Pubmed | Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity. | 7.23e-06 | 2 | 94 | 2 | 12640454 | |
| Pubmed | Myosin heavy chains IIa and IId are functionally distinct in the mouse. | 7.23e-06 | 2 | 94 | 2 | 9585413 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 19109430 | ||
| Interaction | STK4 interactions | 2.91e-09 | 159 | 92 | 10 | int:STK4 | |
| Interaction | CDK3 interactions | 5.13e-08 | 114 | 92 | 8 | int:CDK3 | |
| Interaction | STK3 interactions | 1.43e-07 | 181 | 92 | 9 | int:STK3 | |
| Interaction | RSPH6A interactions | 4.45e-07 | 34 | 92 | 5 | int:RSPH6A | |
| Interaction | TSPAN33 interactions | 5.10e-07 | 65 | 92 | 6 | int:TSPAN33 | |
| Interaction | PRKAG2 interactions | 6.69e-07 | 68 | 92 | 6 | int:PRKAG2 | |
| Interaction | LZTR1 interactions | 7.57e-07 | 111 | 92 | 7 | int:LZTR1 | |
| Interaction | LRRFIP2 interactions | 1.08e-06 | 117 | 92 | 7 | int:LRRFIP2 | |
| Interaction | ASAH2 interactions | 1.82e-06 | 6 | 92 | 3 | int:ASAH2 | |
| Interaction | MYH8 interactions | 3.90e-06 | 52 | 92 | 5 | int:MYH8 | |
| Interaction | MYL3 interactions | 4.78e-06 | 25 | 92 | 4 | int:MYL3 | |
| Interaction | ABTB2 interactions | 6.87e-06 | 101 | 92 | 6 | int:ABTB2 | |
| Interaction | BCAP31 interactions | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH13 MYH7B NTRK1 MYH15 | 8.12e-06 | 554 | 92 | 12 | int:BCAP31 |
| Interaction | ACTN2 interactions | 1.34e-05 | 171 | 92 | 7 | int:ACTN2 | |
| Interaction | TMEM260 interactions | 2.55e-05 | 13 | 92 | 3 | int:TMEM260 | |
| Interaction | TPM1 interactions | 2.73e-05 | 263 | 92 | 8 | int:TPM1 | |
| Interaction | MYL12A interactions | 2.82e-05 | 192 | 92 | 7 | int:MYL12A | |
| Interaction | MYL12B interactions | 4.07e-05 | 138 | 92 | 6 | int:MYL12B | |
| Interaction | MYO5A interactions | 4.16e-05 | 204 | 92 | 7 | int:MYO5A | |
| Interaction | LRRC31 interactions | 4.29e-05 | 205 | 92 | 7 | int:LRRC31 | |
| Interaction | AURKC interactions | 4.38e-05 | 43 | 92 | 4 | int:AURKC | |
| Interaction | S100A4 interactions | 5.16e-05 | 144 | 92 | 6 | int:S100A4 | |
| Interaction | TLE3 interactions | 5.53e-05 | 376 | 92 | 9 | int:TLE3 | |
| Interaction | MYH6 interactions | 7.08e-05 | 94 | 92 | 5 | int:MYH6 | |
| Interaction | SHD interactions | 7.15e-05 | 18 | 92 | 3 | int:SHD | |
| Interaction | ACTN4 interactions | 8.88e-05 | 400 | 92 | 9 | int:ACTN4 | |
| Interaction | RNF123 interactions | MYH1 MYH3 MYH4 MYH9 SETX ADAMTS9 KCNG1 MYO19 OBSCN ST3GAL4 CHD6 ITGAE PLXNB3 | 9.16e-05 | 824 | 92 | 13 | int:RNF123 |
| Interaction | MTHFD1L interactions | 9.91e-05 | 162 | 92 | 6 | int:MTHFD1L | |
| Interaction | DPM2 interactions | 1.08e-04 | 54 | 92 | 4 | int:DPM2 | |
| Interaction | PPP5D1P interactions | 1.23e-04 | 4 | 92 | 2 | int:PPP5D1P | |
| Interaction | MYL6B interactions | 1.37e-04 | 108 | 92 | 5 | int:MYL6B | |
| Interaction | HSPB8 interactions | 1.38e-04 | 172 | 92 | 6 | int:HSPB8 | |
| Interaction | KRT40 interactions | 1.64e-04 | 434 | 92 | 9 | int:KRT40 | |
| Interaction | PIK3C3 interactions | 1.76e-04 | 114 | 92 | 5 | int:PIK3C3 | |
| Interaction | SBDS interactions | 1.82e-04 | 181 | 92 | 6 | int:SBDS | |
| Interaction | LATS1 interactions | 1.82e-04 | 440 | 92 | 9 | int:LATS1 | |
| Interaction | MYH10 interactions | 2.38e-04 | 359 | 92 | 8 | int:MYH10 | |
| Interaction | PALLD interactions | 2.51e-04 | 123 | 92 | 5 | int:PALLD | |
| Interaction | SHC1 interactions | 2.51e-04 | 362 | 92 | 8 | int:SHC1 | |
| Interaction | SLC39A3 interactions | 2.96e-04 | 70 | 92 | 4 | int:SLC39A3 | |
| Interaction | SLFN11 interactions | 3.24e-04 | 376 | 92 | 8 | int:SLFN11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 2.68e-09 | 346 | 94 | 10 | chr17p13 | |
| Cytoband | 17p13.1 | 4.71e-06 | 118 | 94 | 5 | 17p13.1 | |
| Cytoband | 17p13 | 4.75e-05 | 34 | 94 | 3 | 17p13 | |
| Cytoband | 20q12 | 1.11e-03 | 24 | 94 | 2 | 20q12 | |
| Cytoband | 17q12 | 1.13e-03 | 99 | 94 | 3 | 17q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr20q12 | 1.31e-03 | 26 | 94 | 2 | chr20q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | 3.62e-03 | 149 | 94 | 3 | chr17q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p21 | 3.82e-03 | 503 | 94 | 5 | chr6p21 | |
| GeneFamily | Myosin heavy chains | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B MYH15 | 3.74e-30 | 15 | 75 | 13 | 1098 |
| GeneFamily | Patatin like phospholipase domain containing | 7.48e-04 | 10 | 75 | 2 | 466 | |
| GeneFamily | Ras association domain family | 7.48e-04 | 10 | 75 | 2 | 1198 | |
| GeneFamily | UPF1 like RNA helicases | 9.12e-04 | 11 | 75 | 2 | 1169 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 2.49e-03 | 18 | 75 | 2 | 1160 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.60e-03 | 66 | 75 | 3 | 722 | |
| GeneFamily | Sialyltransferases | 3.07e-03 | 20 | 75 | 2 | 438 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 7.19e-07 | 20 | 94 | 4 | M1123 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 8.86e-07 | 21 | 94 | 4 | MM1102 | |
| Coexpression | GSE29949_DC_BRAIN_VS_MONOCYTE_BONE_MARROW_UP | 7.66e-06 | 199 | 94 | 7 | M8418 | |
| Coexpression | HALLMARK_MYOGENESIS | 7.92e-06 | 200 | 94 | 7 | M5909 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(Neuron.Gad1Gad2.Sst-Nr2f2)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.11e-07 | 62 | 94 | 5 | 9db88da996b9977f5a89afe505cd55e7b5324bc9 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(Neuron.Gad1Gad2.Sst-Nr2f2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.11e-07 | 62 | 94 | 5 | 461d280a1b955033186cfc326f9ace85b4a53c54 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Esm1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.58e-07 | 131 | 94 | 6 | 3cb4b272e28ee9bad6d874f64a7aae18352a6cfb | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.25e-07 | 144 | 94 | 6 | 71107275767a0728541a3695715c44874b3e5efc | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Syt15_(Medial_habenula)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.27e-07 | 77 | 94 | 5 | 7f624e9262bd0dc2ac4176f43c91a4bc0f521fe5 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.06e-07 | 147 | 94 | 6 | 50e86860a94be103092c40e39a172eac92372f0d | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Stem_cells-stem_cells_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 8.58e-07 | 152 | 94 | 6 | 375c9ef88c7703a002e868645a722c35e046ef1e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.16e-06 | 160 | 94 | 6 | 0bfdaf979e6f128cba2928ce16bca4d3deff8ac9 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-06 | 165 | 94 | 6 | 7c771f22b58989572c939ed127e637ec28dc0dca | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.89e-06 | 174 | 94 | 6 | ccc79febfcf588d8294ffc712338be96de8a5033 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.77e-06 | 186 | 94 | 6 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 3.64e-06 | 195 | 94 | 6 | 120296531bbc8080dcabacbd64733cc1dc34603a | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.88e-06 | 125 | 94 | 5 | d05556ea185c15815a4f8643f1c01185badbeece | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.02e-06 | 129 | 94 | 5 | f83187c0bb06528127b8d2d56674ab1946846951 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.08e-06 | 62 | 94 | 4 | a20620a8869721ea62984c2022ee1b484b455824 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.08e-06 | 62 | 94 | 4 | ee694c06bcd924b4ddf744178ba3a99e04eed51b | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Grp_(Neuron.Slc17a6.Grp)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.10e-05 | 65 | 94 | 4 | b7bc23af54d6d2f7afd584f4df42c24d7c49e344 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Grp_(Neuron.Slc17a6.Grp)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.10e-05 | 65 | 94 | 4 | 3b3630253f5713c4a688c74c4ea0f98c1fe42594 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.07e-05 | 157 | 94 | 5 | 741d79c10cb87fa7f14080c6fccb1553c3a20bad | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.14e-05 | 158 | 94 | 5 | 41cf950983f47a9e55d56041b301006b42853b37 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Enterocyte_(Proximal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 159 | 94 | 5 | 709b57f992a29878cc899d760d144d36cb5cb280 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.34e-05 | 161 | 94 | 5 | 1e17a993126e1f2a25ee7dfbb95a74ccb2a26791 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-05 | 164 | 94 | 5 | 382e42701779d12a7948690b3be72d06dd75c8b4 | |
| ToppCell | Control-Myeloid-MoAM1,_IL1R2|Control / Condition, Lineage and Cell class | 2.79e-05 | 167 | 94 | 5 | ab6029ba037b6a499da8758864c44e174cde5587 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.79e-05 | 167 | 94 | 5 | 91b14df450bfb6a2b406c88f8c75cd51eeb9e82b | |
| ToppCell | Control-Myeloid-MoAM1,_IL1R2|Myeloid / Condition, Lineage and Cell class | 2.79e-05 | 167 | 94 | 5 | 6e5140527437193f441ca96893b9a00d346614f3 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.04e-05 | 170 | 94 | 5 | 8ab67e2b6e30fdf9e9a2c02e31d4df34e751a3ed | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 171 | 94 | 5 | 9498c35b2a2c3a339dc8c5d49c8ec20d8ad52753 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.12e-05 | 171 | 94 | 5 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 171 | 94 | 5 | db544252f98e073e5bb4bec4a110cd58e6434435 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.30e-05 | 173 | 94 | 5 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.49e-05 | 175 | 94 | 5 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | 3'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.20e-05 | 182 | 94 | 5 | d996ceb77c83591df4cef144ca72862f31d9777f | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.20e-05 | 182 | 94 | 5 | c3eafdc11858566aa7692b2f5dbe72ac01fb769a | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.20e-05 | 182 | 94 | 5 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 4.32e-05 | 183 | 94 | 5 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.32e-05 | 183 | 94 | 5 | 274483009b309289e4cb84beedf6806430db6ff6 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.32e-05 | 183 | 94 | 5 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 4.32e-05 | 183 | 94 | 5 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.54e-05 | 185 | 94 | 5 | 3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.78e-05 | 187 | 94 | 5 | 82bbc107f58c623f3b90430c90c562624a12abef | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor | 4.78e-05 | 187 | 94 | 5 | 1e52d3d9d664c813d859b5b75e4c07b218818f95 | |
| ToppCell | Control-Endothelial-VE_Peribronchial|Control / Disease state, Lineage and Cell class | 4.91e-05 | 188 | 94 | 5 | f5b7dbc89f992c13280d36a34935be83906b1bc0 | |
| ToppCell | Control-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 5.03e-05 | 189 | 94 | 5 | f83f7521e377ded1522639e9a35c98b3e2725bac | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.16e-05 | 190 | 94 | 5 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | Control-Endothelial-VE_Venous|Control / Disease state, Lineage and Cell class | 5.29e-05 | 191 | 94 | 5 | 617546cf4883dedf3323e03a53ba5adec334cf8e | |
| ToppCell | Control-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 5.29e-05 | 191 | 94 | 5 | 2da83c493e60ad0278848957645277d76737a188 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 5.29e-05 | 191 | 94 | 5 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.33e-05 | 97 | 94 | 4 | f3c3fb260954f594a9ab8e1ac9a01115767cbc7a | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-SVEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.42e-05 | 192 | 94 | 5 | c3dda7c48732b0b8bde36de282d64192f5e9b98f | |
| ToppCell | IPF-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 5.42e-05 | 192 | 94 | 5 | 9b06c7336624ef21f8e5393725b56038a8028e57 | |
| ToppCell | (5)_Epithelial_cells-(5)_Epi_basal|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 5.69e-05 | 194 | 94 | 5 | b887b2ff19b76bd93c67f9a24762efae816efd45 | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.69e-05 | 194 | 94 | 5 | f772a9f9ef8635aeaeb8b022dbb94e9672b36ead | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic-LEC-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.69e-05 | 194 | 94 | 5 | 3b73f2d305a7566f7ab567e5f18c82cd3d80e32c | |
| ToppCell | IPF-Endothelial|IPF / Disease state, Lineage and Cell class | 5.69e-05 | 194 | 94 | 5 | 9591993aa2dcba3d09a0f1ea8b8f2439c26482d6 | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.69e-05 | 194 | 94 | 5 | 5d2b3ed5374e2ab10c1c7eb3a03139fc95036a48 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|IPF / Disease state, Lineage and Cell class | 5.83e-05 | 195 | 94 | 5 | 2c3ad3cb79f11119ac69c413a938d21199145040 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Club|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.83e-05 | 195 | 94 | 5 | b9e8f405f6d837bb39b615836d3e2df349737c0e | |
| ToppCell | distal-1-Hematologic-B_cell|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.98e-05 | 196 | 94 | 5 | f442060d743b3ad2f9e5e343d4696411eef7f498 | |
| ToppCell | distal-Hematologic-B_cell-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.98e-05 | 196 | 94 | 5 | be520c09d7e41d08d5f5154bfed3d67c7c1067d4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.12e-05 | 197 | 94 | 5 | 3332b9b5bf78f0203ebbd94257a36e9054d896c3 | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Smooth_muscle|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.12e-05 | 197 | 94 | 5 | 98f0184a09563a544f0c2d4df22c9db2fbc95019 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.12e-05 | 197 | 94 | 5 | 71367bebc23d0e81f60f780d6b0ab3a1783ac014 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.12e-05 | 197 | 94 | 5 | 0f9836554ace3f9d155ebafdd719aa26466ca44e | |
| ToppCell | tumor_Lung-Fibroblasts-Smooth_muscle_cells|Fibroblasts / Location, Cell class and cell subclass | 6.27e-05 | 198 | 94 | 5 | f540f464118edc0fb809ebcb813d0302e6952253 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 6.42e-05 | 199 | 94 | 5 | c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.42e-05 | 199 | 94 | 5 | 7223f853335492ca617dbec3e4b6872a8a463a45 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.42e-05 | 199 | 94 | 5 | b768496381362f9a2706e0892b5a7a0db82e09ce | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | ab4fda0cc95cb8f80ea9f28745013f3248def820 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 6.58e-05 | 200 | 94 | 5 | 61d7dd0a78942b069c3f5e75044368dc00e6e8e6 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar-AT1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.58e-05 | 200 | 94 | 5 | 3d51aebf626dd4656ab4aac8a20d761b8062c42d | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 6.58e-05 | 200 | 94 | 5 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 | |
| ToppCell | PND07-28-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.00e-04 | 114 | 94 | 4 | 1c99483a492d08b6bb745006fe24c22841dc57ad | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.30e-04 | 122 | 94 | 4 | 1ed865f0ecfe304fb86313ff51c04e9052357270 | |
| ToppCell | facs-Thymus-Epithelium-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-04 | 132 | 94 | 4 | 6f711fe84135406a8114a898a14c5ea0dfad74f2 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Gpr139|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.86e-04 | 134 | 94 | 4 | 917b8951dd4c870b6b92f2e73e02dac884330c30 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Efna5_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.03e-04 | 54 | 94 | 3 | 13431c23a110070a11de41773233a8d6583d902c | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Efna5_(Deep_layer_pyramidal_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.03e-04 | 54 | 94 | 3 | cd64ee5c47df5dba0cea954cb115a8de0efb55d1 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Nefm_(Layer_6a)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.14e-04 | 55 | 94 | 3 | b0d37faccc8d04433ee0e76cbce2410530c4c8a1 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Nefm_(Layer_6a)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.14e-04 | 55 | 94 | 3 | c3ebea1420b68638ed465a8cd8efba860650b795 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Sphkap|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.26e-04 | 56 | 94 | 3 | af55596513ddbe60b08648b27e41a7b65e3da58c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Granulocytic-Neutrophil-Neu_c3-CST7|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.45e-04 | 144 | 94 | 4 | b638398f559e7fd9d4294d1c830beeb20f905960 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.72e-04 | 148 | 94 | 4 | 4d43efee96a6493abd78e9ca41aab73db0c80626 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.87e-04 | 150 | 94 | 4 | 9d5bbdca19da60e1a2121ef64ec8e1375a5dbf6d | |
| ToppCell | normal_Lung-T/NK_cells-Naive_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 2.87e-04 | 150 | 94 | 4 | b81f8dfc7755252c457e38bb32b103af3b6f1c01 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-04 | 152 | 94 | 4 | d5ba87b5d34e52cef8475befafea962d70fa8a1d | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-04 | 152 | 94 | 4 | d88d68a788a3256671ebbc06e104833f1f58f07d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.09e-04 | 153 | 94 | 4 | 83942ef63d21725fa15ed5a91481d1f9936e8f11 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-04 | 154 | 94 | 4 | e51a5114f0ec38f997f5b8bbf3a7770f98595474 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Cpa6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.17e-04 | 154 | 94 | 4 | 12cbc38bc1f7231c67e1d2d5e86e95bc12e24682 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.20e-04 | 63 | 94 | 3 | 55f11bb2970a8159166e71af34a0446ecee594e6 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.36e-04 | 64 | 94 | 3 | 0f13fbeda23ab9df3488cfae98cb6cd7a3c1b332 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.66e-04 | 160 | 94 | 4 | 7d34159363d274019e14549d1186c629ce990691 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.66e-04 | 160 | 94 | 4 | fe5fb0e7a79862f63529721f0a82f4f6d231d3ca | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 3.75e-04 | 161 | 94 | 4 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.75e-04 | 161 | 94 | 4 | dccb61d5e17a8f1c6d1fc146ee389f567659a0f0 | |
| Drug | formycin triphosphate | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B | 1.65e-18 | 51 | 94 | 12 | CID000122274 |
| Drug | purealin | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B | 9.04e-18 | 58 | 94 | 12 | CID006419303 |
| Drug | fast white | 1.16e-15 | 42 | 94 | 10 | CID000024008 | |
| Drug | S-(-)-Etomoxir | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B | 9.26e-15 | 100 | 94 | 12 | CID000060765 |
| Drug | AC1NRBPQ | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH10 MYH11 PNPLA6 MYH13 FCER2 MYH7B ST3GAL4 | 1.51e-14 | 137 | 94 | 13 | CID005288569 |
| Drug | blebbistatin | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B | 5.75e-14 | 116 | 94 | 12 | CID003476986 |
| Drug | B0683 | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B | 6.38e-14 | 117 | 94 | 12 | CID006398969 |
| Drug | clenbuterol | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B | 6.67e-13 | 142 | 94 | 12 | CID000002783 |
| Drug | candesartan cilexetil | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B | 8.57e-13 | 145 | 94 | 12 | CID000002540 |
| Drug | oxovanadium | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH10 MYH11 PNPLA6 MYH13 MYH7B | 2.61e-12 | 120 | 94 | 11 | CID000024411 |
| Drug | SM-2 | 2.71e-12 | 87 | 94 | 10 | CID000486033 | |
| Drug | carvedilol | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B | 2.99e-12 | 161 | 94 | 12 | CID000002585 |
| Drug | AC1LADJ6 | 6.32e-12 | 130 | 94 | 11 | CID000486032 | |
| Drug | 4-chloroaniline | HMGN2P46 MYH1 MYH2 MYH3 MYH4 MYH6 ERBB2 MYH8 MYH10 MYH11 MYH13 MYH7B | 4.33e-11 | 202 | 94 | 12 | CID000007812 |
| Drug | 2bq7 | 9.01e-11 | 123 | 94 | 10 | CID006540267 | |
| Drug | AC1L1IZ2 | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 SETX MYH13 MYH14 MYH7B | 3.80e-10 | 304 | 94 | 13 | CID000004795 |
| Drug | NSC339663 | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B | 5.08e-10 | 250 | 94 | 12 | CID000003892 |
| Drug | AC1N9ZZC | 6.01e-10 | 149 | 94 | 10 | CID004369374 | |
| Drug | NSC107658 | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B | 5.01e-09 | 306 | 94 | 12 | CID000002919 |
| Drug | creatine | 7.40e-09 | 193 | 94 | 10 | CID000000586 | |
| Drug | trifluoperazine | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B | 9.47e-09 | 324 | 94 | 12 | CID000005566 |
| Drug | nocodazole | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B RABAC1 CTBP2 | 9.80e-09 | 477 | 94 | 14 | CID000004122 |
| Drug | N-ethylmaleimide | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B RABAC1 PAPOLG | 2.32e-08 | 511 | 94 | 14 | CID000004362 |
| Drug | MgCl2 | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B | 2.52e-08 | 354 | 94 | 12 | CID000024584 |
| Drug | wartmannin | MYH1 MYH2 MYH3 MYH4 MYH6 ERBB2 MYH8 MYH9 MYH10 MYH11 MYH13 FCER2 MYH14 MYH7B NTRK1 ST3GAL4 S1PR3 | 3.26e-08 | 811 | 94 | 17 | CID000005691 |
| Drug | eye gene | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B | 3.98e-08 | 369 | 94 | 12 | CID000004782 |
| Drug | pyrophosphate | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 ISYNA1 MYH13 PAPOLA MYH14 MYH7B PAPOLG | 7.26e-08 | 654 | 94 | 15 | CID000001023 |
| Drug | verapamil | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 KCNG1 MYH7B | 1.12e-07 | 490 | 94 | 13 | CID000002520 |
| Drug | NSC226080 | MYH1 MYH2 MYH3 MYH4 MYH6 ERBB2 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B NTRK1 LRP1 CTU1 | 1.21e-07 | 782 | 94 | 16 | CID000005040 |
| Drug | D-triiodothyronine | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B | 1.22e-07 | 409 | 94 | 12 | CID000000861 |
| Drug | nifedipine | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B | 1.42e-07 | 415 | 94 | 12 | CID000004485 |
| Drug | LY294002 | MYH1 MYH2 MYH3 MYH4 MYH6 ERBB2 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B NTRK1 S1PR3 | 4.07e-07 | 748 | 94 | 15 | CID000003973 |
| Drug | isoproterenol | HMGN2P46 MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 P2RX5 MYH14 MYH7B | 6.23e-07 | 669 | 94 | 14 | CID000003779 |
| Drug | NSC9700 | HMGN2P46 MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH10 MYH11 MYH13 INHBB MYH7B CAPN10 | 7.30e-07 | 578 | 94 | 13 | CID000005408 |
| Drug | carbachol | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 FCER2 MYH14 MYH7B NFKBIE | 8.68e-07 | 688 | 94 | 14 | CID000002551 |
| Drug | NSC611747 | 1.96e-06 | 352 | 94 | 10 | CID000002534 | |
| Drug | K-Cl | MYH1 MYH2 MYH3 MYH4 MYH6 MYH8 MYH9 MYH10 MYH11 MYH13 MYH14 MYH7B | 3.78e-06 | 567 | 94 | 12 | CID000004873 |
| Drug | 4-epidoxorubicin | MYH1 MYH2 MYH3 MYH4 MYH6 ERBB2 MYH8 MYH10 MYH11 MYH13 SMUG1 MYH7B DHRSX HDAC7 | 4.23e-06 | 788 | 94 | 14 | CID000001690 |
| Drug | Methylprednisolone, 6-alpha [83-43-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.77e-05 | 197 | 94 | 7 | 6785_DN | |
| Drug | Sparteine (-) [90-39-1]; Down 200; 17uM; HL60; HT_HG-U133A | 1.95e-05 | 200 | 94 | 7 | 2134_DN | |
| Drug | Dextromethorphan hydrobromide monohydrate [6700-34-1]; Up 200; 10.8uM; HL60; HT_HG-U133A | 1.95e-05 | 200 | 94 | 7 | 1281_UP | |
| Drug | Hypochlorous Acid | 3.22e-05 | 387 | 94 | 9 | ctd:D006997 | |
| Drug | Ciguatoxins | DEFA4 MYH1 MYH2 MYH4 MYH9 INHBB NFKBIE MYLIP LRP1 DIDO1 PLPBP RASSF7 MVD | 4.33e-05 | 845 | 94 | 13 | ctd:D002922 |
| Drug | AC1L2GOW | 7.38e-05 | 20 | 94 | 3 | CID000046762 | |
| Drug | AC1O4QIW | 1.04e-04 | 59 | 94 | 4 | CID006398478 | |
| Drug | Spermine | 1.35e-04 | 63 | 94 | 4 | ctd:D013096 | |
| Drug | Bepridil hydrochloride [74764-40-2]; Up 200; 10uM; HL60; HT_HG-U133A | 1.55e-04 | 194 | 94 | 6 | 1274_UP | |
| Drug | Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Down 200; 11.8uM; HL60; HT_HG-U133A | 1.64e-04 | 196 | 94 | 6 | 2158_DN | |
| Drug | F0447-0125; Up 200; 10uM; PC3; HT_HG-U133A | 1.64e-04 | 196 | 94 | 6 | 6401_UP | |
| Drug | CAY10397; Up 200; 10uM; PC3; HT_HG-U133A | 1.64e-04 | 196 | 94 | 6 | 7071_UP | |
| Drug | Norcyclobenzaprine [303-50-4]; Down 200; 15.4uM; PC3; HT_HG-U133A | 1.68e-04 | 197 | 94 | 6 | 4190_DN | |
| Drug | (S)-(-)-Atenolol [93379-54-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.73e-04 | 198 | 94 | 6 | 5325_DN | |
| Drug | dimethyl phthalate | CYLD MYH1 ERBB2 SETX PNPLA6 KALRN NTRK1 TUBGCP3 MUC5AC HDAC7 CAPN10 | 1.73e-04 | 714 | 94 | 11 | ctd:C024629 |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 1.78e-04 | 199 | 94 | 6 | 6942_DN | |
| Drug | Oxantel pamoate [68813-55-8]; Down 200; 6.6uM; HL60; HT_HG-U133A | 1.78e-04 | 199 | 94 | 6 | 1277_DN | |
| Drug | Thiethylperazine malate [52239-63-1]; Down 200; 6uM; HL60; HT_HG-U133A | 1.78e-04 | 199 | 94 | 6 | 6154_DN | |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Up 200; 11.6uM; PC3; HT_HG-U133A | 1.83e-04 | 200 | 94 | 6 | 4202_UP | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.68e-22 | 10 | 91 | 9 | DOID:0110454 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.68e-22 | 10 | 91 | 9 | DOID:0111269 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.68e-22 | 10 | 91 | 9 | DOID:0080719 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.68e-22 | 10 | 91 | 9 | DOID:0111602 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.68e-22 | 10 | 91 | 9 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.68e-22 | 10 | 91 | 9 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.68e-22 | 10 | 91 | 9 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.68e-22 | 10 | 91 | 9 | DOID:0111596 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 3.67e-21 | 12 | 91 | 9 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 3.67e-21 | 12 | 91 | 9 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.19e-20 | 13 | 91 | 9 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 8.28e-20 | 15 | 91 | 9 | DOID:0050646 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 2.83e-16 | 71 | 91 | 11 | DOID:0050700 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 2.55e-14 | 48 | 91 | 9 | DOID:423 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 6.45e-14 | 80 | 91 | 10 | DOID:12930 (implicated_via_orthology) | |
| Disease | EMILIN-3 measurement | 2.82e-05 | 3 | 91 | 2 | EFO_0801563 | |
| Disease | Hyalinosis, Segmental Glomerular | 8.79e-05 | 28 | 91 | 3 | C0086432 | |
| Disease | Focal glomerulosclerosis | 1.88e-04 | 36 | 91 | 3 | C0017668 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 2.60e-04 | 8 | 91 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | blindness (implicated_via_orthology) | 2.60e-04 | 8 | 91 | 2 | DOID:1432 (implicated_via_orthology) | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 2.60e-04 | 8 | 91 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | leprosy | 2.96e-04 | 103 | 91 | 4 | EFO_0001054 | |
| Disease | Distal arthrogryposis | 3.34e-04 | 9 | 91 | 2 | cv:C0265213 | |
| Disease | Malignant Head and Neck Neoplasm | 3.43e-04 | 44 | 91 | 3 | C0278996 | |
| Disease | Head and Neck Carcinoma | 4.17e-04 | 10 | 91 | 2 | C3887461 | |
| Disease | Neuroblastoma | 4.17e-04 | 47 | 91 | 3 | C0027819 | |
| Disease | Dental enamel hypoplasia | 6.08e-04 | 12 | 91 | 2 | EFO_1001304 | |
| Disease | tumor necrosis factor ligand superfamily member 8 measurement | 7.18e-04 | 13 | 91 | 2 | EFO_0010592 | |
| Disease | glucose homeostasis measurement, glucose effectiveness measurement | 9.62e-04 | 15 | 91 | 2 | EFO_0006833, EFO_0006896 | |
| Disease | bipolar I disorder | 9.68e-04 | 141 | 91 | 4 | EFO_0009963 | |
| Disease | resting heart rate | 1.19e-03 | 149 | 91 | 4 | EFO_0004351 | |
| Disease | stomach carcinoma (is_marker_for) | 2.48e-03 | 24 | 91 | 2 | DOID:5517 (is_marker_for) | |
| Disease | Neoplasm Invasiveness | 2.56e-03 | 184 | 91 | 4 | C0027626 | |
| Disease | descending aortic diameter | 2.58e-03 | 88 | 91 | 3 | EFO_0021788 | |
| Disease | platelet measurement | 2.95e-03 | 315 | 91 | 5 | EFO_0005036 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RGQECVEECRVLQGL | 536 | P04626 | |
| NLAERCEQRLALRCG | 671 | Q9BZ76 | |
| VRLCRLCQGVLGSVR | 681 | Q8TER5 | |
| RQRLDRICEGIRPQI | 11 | P56545 | |
| IVSRNGRDACRELIG | 301 | Q9BXY5 | |
| GCDRSQNLVDICRER | 431 | Q96BT7 | |
| VLCNEAGLCALRRIL | 566 | Q8NB90 | |
| RELQGQAGQCILLLR | 246 | Q9HC96 | |
| LIRDIINRRCGNNPL | 1236 | O60306 | |
| IICCRGDQVRLAVRV | 621 | Q8TAP6 | |
| CCTDLRGLELRVQRN | 151 | Q02833 | |
| QGRCLRCHVLQARDL | 131 | O95294 | |
| TILRGGVRRCLQQQC | 51 | Q9UBG7 | |
| GREVLRQALRCTNCK | 141 | Q8WWW0 | |
| RQRSCIENILRACVG | 481 | Q9NPH2 | |
| AERVGNRGRIICITN | 151 | Q9NVM9 | |
| ECVQRCTRTLQAEGR | 301 | Q96SQ7 | |
| QDVRQALGRPVLLRC | 546 | Q8NFP4 | |
| IRCIRSLNGCRVTDE | 196 | Q9NRJ5 | |
| RCLRQADCILIVGLG | 866 | Q8IY17 | |
| VLLRCQVEGRGLEQA | 211 | P04629 | |
| GRARVLEQCARCIQG | 756 | Q96H55 | |
| GENVLLGCERREQCR | 596 | Q5IJ48 | |
| RGGRILQDDLTCRAV | 2506 | Q07954 | |
| RLVVRRALCQAGQPQ | 276 | Q8WXK4 | |
| QRQHLACARCLLEGR | 336 | O00221 | |
| RGERRLNLDVQCDSC | 241 | P09529 | |
| NNCRIGLQPAVLRRA | 1051 | Q2LD37 | |
| EIIEGCRLPVLRRNQ | 6 | Q92993 | |
| RLSRNCREDPQGCLL | 86 | Q86SG4 | |
| QRRRLQCSDVRSCLG | 736 | P38570 | |
| LRCNGVLEGIRICRQ | 716 | Q7Z406 | |
| QLRCNGVLEGIRICR | 741 | A7E2Y1 | |
| LRCNGVLEGIRICRK | 696 | P13535 | |
| ACGQVRQGVCETRRL | 131 | Q9ULL4 | |
| LHQLRCNGVLEGIRI | 696 | Q9UKX2 | |
| RCQQGGIDTRIRGLE | 951 | Q14999 | |
| RCCRRGTQIVLLGLV | 16 | P06734 | |
| NVVVCLAVGLNRRLR | 36 | P25021 | |
| DREGQRLLQCIRCSD | 246 | O60229 | |
| CLNQVCRRLGIIEVD | 26 | Q8WY64 | |
| QPRLQACLREIRCLA | 76 | P53602 | |
| VLLQNLCCRILGRSE | 11 | Q96CW5 | |
| CQPEDRRRRIIINVG | 56 | Q9UIX4 | |
| QLRCNGVLEGIRICR | 696 | P12882 | |
| QLRCNGVLEGIRICR | 691 | P35579 | |
| CRALEGGQAEVRLRR | 191 | O15553 | |
| LRTCRNPRGDCLRDV | 1186 | P98088 | |
| TQRCVRQADCILIVG | 811 | Q6ZV29 | |
| LRQEGTRCELQICGL | 3496 | Q5VST9 | |
| KNLDIRCIRSLNGCR | 191 | P51003 | |
| RCIRSLNGCRVTDEI | 196 | P51003 | |
| SLDIRCIRSLNGCRV | 191 | Q9BWT3 | |
| GIRTRLVVCQRSNGE | 1401 | Q9P2N4 | |
| NRALRELVAECGGRV | 171 | Q8WWP7 | |
| RGTDNILQVCQRRRV | 101 | Q8WUS8 | |
| IELFNRCRGHCLERQ | 226 | O75319 | |
| QRLCLGRNRSCAAEL | 136 | Q5R3K3 | |
| QRCNRKELCRPEILG | 1406 | Q8TD26 | |
| RALCQACALLDGLNR | 296 | Q7Z7A3 | |
| VGAAVILAQLLRRCR | 16 | Q8N5I4 | |
| CVGISEARGRLLERN | 296 | Q9BTC0 | |
| VVQRDCRRRGQEAVC | 661 | O75578 | |
| CRRRGQEAVCLTAAL | 666 | O75578 | |
| QRVAQVEGACRRLGL | 691 | Q9NT22 | |
| LSERCQRQLQSLCRG | 156 | Q9HB96 | |
| QERGLRSQCECLRGR | 556 | Q8WUI4 | |
| LDSRRIQGCARRLLC | 926 | Q9NQC7 | |
| FCRRTELRVGNCLIG | 71 | P12838 | |
| RLVCNCLVRGRGARA | 311 | Q99500 | |
| NVALGNAIRIRILCC | 256 | Q8TEX9 | |
| LDQLRCNGVLEGIRI | 696 | P35580 | |
| NLAERCEQRLALRCG | 671 | Q96NU0 | |
| RCLRRENLARGTCEI | 151 | Q93086 | |
| GILCVADRCQGLREL | 221 | Q9UKT6 | |
| LQQLLVRRVGEICRE | 1951 | Q5T011 | |
| GELERAVQRLSGCQR | 671 | Q8IYR2 | |
| VLQQLRCNGVLEGTR | 701 | Q9Y2K3 | |
| IILCRNLENIEAGRG | 86 | Q6ZNJ1 | |
| RNCPLCRRGILQTLN | 416 | Q9BY78 | |
| RQRALCRGGREIQRQ | 2096 | Q7Z333 | |
| NIQSLRCRRCVVVGN | 111 | Q11206 | |
| ALDSLRCRRCIIVGN | 151 | Q11203 | |
| RCRRCIIVGNGGVLA | 156 | Q11203 | |
| QLRCNGVLEGIRICR | 696 | Q9Y623 | |
| LHQLRCNGVLEGIRI | 691 | P11055 | |
| RCNGVLEGIRICRKG | 696 | P13533 | |
| LGVGCALRAVNERVQ | 11 | O94903 | |
| LEQLRCNGVLEGIRI | 696 | P35749 | |
| RRLQVLQEGVLCRTL | 191 | Q9Y3P4 | |
| RLCGAVPVRDQARIQ | 41 | Q96MF0 | |
| RQLLPCARVQICRAQ | 306 | Q86XI8 | |
| CARVQICRAQGLETL | 311 | Q86XI8 | |
| LREEECILACRGVQG | 291 | O43278 | |
| LIVAACCRIVEARGL | 921 | Q9P227 | |
| CLEAVLRRLQGQCRQ | 461 | Q86SX3 | |
| QLRCNGVLEGIRICR | 696 | Q9UKX3 | |
| QREQLLGICDAALCR | 186 | Q53HV7 | |
| RPRNLGELCQRLVRN | 56 | Q9UI14 | |
| RLQGQLCDVSIRVQG | 51 | O15209 | |
| LNRLIQRIRCEIGNV | 361 | Q7RTS7 |